Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-25

FDA Approved: PILOCARPINE HYDROCHLORIDE — Original Application (Somerset Therapeutics, LLC)

View source ↗

Summary

FDA approves Somerset Therapeutics, LLC original application for pilocarpine hydrochloride ophthalmic solution (generic).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pilocarpine hydrochloride ophthalmic solution (PILOCARPINE HYDROCHLORIDE)

Snippet

ORIG AP for PILOCARPINE HYDROCHLORIDE (PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION)